Menu Search
Equities

Rohto Pharmaceutical Co Ltd

RPHCF:PKL

Rohto Pharmaceutical Co Ltd

Actions
  • Price (USD)21.54
  • Today's Change0.00 / 0.00%
  • Shares traded432.00
  • 1 Year change+2.97%
  • Beta--
Data delayed at least 15 minutes, as of Jul 12 2024 14:04 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

ROHTO PHARMACEUTICAL CO., LTD. is a Japan-based company principally engaged in the health and beauty care area. The Company primarily provides eye care-related products, including eye drops and eye lotions; skin care-related products, including dermatological preparations, lip balms, sunscreens and functional cosmetics; oral medication and food-related products, including digestive medicines, Chinese herbal medicines and supplements, as well as extracorporeal test drugs and other products. The Company operates its business in domestic market and overseas markets, including Europe, Asia and America.

  • Revenue in JPY (TTM)282.05bn
  • Net income in JPY27.26bn
  • Incorporated1949
  • Employees7.26k
  • Location
    Rohto Pharmaceutical Co Ltd1-8-1, Tatsumi-Nishi, Ikuno-kuOSAKA-SHI 544-8666JapanJPN
  • Phone+81 667581231
  • Websitehttps://www.rohto.co.jp/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.